Clinical trials
Completed Digestive System Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
106 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2003 | 1 |
| 2005 | 1 |
| 2007 | 4 |
| 2008 | 2 |
| 2009 | 7 |
| 2010 | 5 |
| 2011 | 4 |
| 2012 | 3 |
| 2013 | 8 |
| 2014 | 8 |
| 2015 | 5 |
| 2016 | 7 |
| 2017 | 10 |
| 2018 | 6 |
| 2019 | 3 |
| 2020 | 9 |
| 2021 | 7 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 106 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Exact Sciences Corporation | 5 |
| Gilead Sciences | 5 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 4 |
| Mirum Pharmaceuticals, Inc. | 3 |
| Novartis Pharmaceuticals | 3 |
| Sumitomo Pharma America, Inc. | 3 |
| Bausch Health Americas, Inc. | 2 |
| Boston Scientific Corporation | 2 |
| Celgene | 2 |
| Children's Hospital Los Angeles | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Digestive System Diseases | 106 |
| Gastrointestinal Diseases | 41 |
| Liver Diseases | 28 |
| Intestinal Diseases | 26 |
| Neoplasms | 24 |
| Digestive System Neoplasms | 23 |
| Colonic Diseases | 20 |
| Neoplasms by Site | 19 |
| Gastrointestinal Neoplasms | 16 |
| Colorectal Neoplasms | 14 |
Trials
Showing 1 to 25 of 106. Each trial links to its page on Pharma Observatory.
6 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.